Dr. Bahgat Fayed PhD (Faculty of Pharmacy, Cairo University); Visiting PhD student (University of York); Master of Pharmaceutical science (King Saud University); Bachelor of pharmaceutical science (Helwan University)
Associated professor, National Research Centre, Cairo · Egypt
Editorial leadership for Journal of Biotechnology and Biomedical Science ISSN 2576-6694
Research interests
- Dr. Fayed's Research Centers On Innovative Strategies For Combating Disease At The Molecular
- Cellular Level: Antimicrobial Resistance
- Biofilms Nanoparticle Drug Delivery Systems Molecular Microbiology
- Biotechnology Cancer Theranostics
- Drug Repurposing Heterologous Expression
- Gene Clusters
Biography
Dr. Bahgat Fayed is an Associate Professor specializing in Molecular Microbiology and Drug Delivery, with a focus on combating Antimicrobial Resistance. His research primarily investigates novel strategies utilizing nanoparticles (e.g., zinc oxide, chitosan) to disrupt microbial defenses, particularly Candida biofilms. Dr. Fayed’s work extends into cancer theranostics and the utilization of microbial and natural resources to produce antifungal peptides. He is committed to developing sustainable and eco-friendly therapeutic alternatives
Achievements
Dr. Fayed has been recognized for his research contributions in the biomedical field:
- Fulbright Egyptian Scholar Program Alumnus.
- His research on Nanoparticles vs. Candida Biofilms has been highlighted internationally.
Grants And Funding
Dr. Fayed's research is supported by institutional and international grants, though specific details are not always public:
- Fulbright Program: Received support as a Fulbright Egyptian Scholar.
- Active Funding: Continues to lead projects focused on antimicrobial resistance and cancer targeting.
Academic Profiles Of Dr. Bahgat Fayed
Explore his academic and professional presence across trusted platforms:
Selected publications
- Production of prebiotic chitooligosaccharide and its nano/microencapsulation for the production of functional yoghurt 2020 cited 63×
- Nanoparticles in the battle against Candida auris biofilms: current advances and future prospects 2024 cited 17×
- Season and Geographic Region Impact Protein 1 Content, Antimicrobial and Cytotoxic Effect of Royal Jelly From Fujairah Emirates Recent 2026
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JBBS for your work?
This journal is guided by Dr. Bahgat Fayed (Associated professor, National Research Centre, Cairo) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.